Pre-eclampsia surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}} {{Sara.Zand}}
{{CMG}} {{AE}} {{Sara.Zand}}
== Delivery ==
== Delivery ==
[[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurence of the following:
[[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence any of the following:
:*Repeated episodes of severe hypertension despite maintenance treatment with 3 classes of antihypertensive agents
:*Repeated episodes of severe hypertension despite maintenance treatment with 3 classes of antihypertensive agents
:*Progressive [[thrombocytopenia]]
:*Progressive [[thrombocytopenia]]
Line 10: Line 10:
:*Abnormal[[ neurological features]], such as severe intractable[[ headache]], repeated [[visual scotomata]],[[ convulsions]]
:*Abnormal[[ neurological features]], such as severe intractable[[ headache]], repeated [[visual scotomata]],[[ convulsions]]
:*Nonreassuring [[fetal status]]
:*Nonreassuring [[fetal status]]


==References==
==References==

Revision as of 12:08, 8 October 2020

Pre-eclampsia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pre-eclampsia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pre-eclampsia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pre-eclampsia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pre-eclampsia surgery

CDC on Pre-eclampsia surgery

Pre-eclampsia surgery in the news

Blogs on Pre-eclampsia surgery

Directions to Hospitals Treating Pre-eclampsia

Risk calculators and risk factors for Pre-eclampsia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]

Delivery

Delivery is the mainstay of therapy for preeclampsia in the 37 weeks of gestation or occurrence any of the following:

References

Template:WH Template:WS